| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $159K | -29.0% | -89.4% |
| Cost of Revenue | $64K | -24.7% | -98.2% |
| Gross Profit | $95K | -31.7% | +104.4% |
| R&D Expense | $20.5M | +16.4% | +1.9% |
| SG&A Expense | $5.8M | +12.9% | -24.7% |
| Operating Income | -$26.2M | -9.5% | +12.5% |
| Pre-tax Income | -$21.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $82.0M | +96.5% | — |
| Short-term Investments | $20.2M | -72.2% | — |
| Accounts Receivable | $28K | -67.1% | — |
| Current Assets | $133.6M | -10.0% | — |
| Total Assets | $146.8M | -11.2% | — |
| Current Liabilities | $17.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$45.0M | — | — |
| Capital Expenditures | $55K | — | — |
| Investing Cash Flow | $5.3M | — | — |
| Financing Cash Flow | $15K | — | — |
| Free Cash Flow | -$45.0M | — | — |
| +23.4% |
| +41.0% |
| Income Tax | $1K | -90.0% | -98.0% |
| Net Income | -$21.0M | +23.4% | +41.0% |
| EPS (Basic) | -$0.15 | +21.1% | +40.0% |
| EPS (Diluted) | -$0.15 | +21.1% | +40.0% |
| +17.7% |
| — |
| Total Liabilities | $72.7M | +2.3% | — |
| Stockholders' Equity | $74.1M | -21.3% | -41.5% |